Study Comparing ABVD vs BEACOPP in Advanced Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Cyclophosphamide
Related studies linked through entity extraction aliases.
Umbilical Cord Blood Transplant for Children With Myeloid Hematological Malignancies
- Status
- COMPLETED
- Phase
- NA
Viral Therapy in Treating Young Patients With Relapsed or Refractory Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Cell Therapy for Metastatic Melanoma Using CD8 Enriched Tumor Infiltrating Lymphocytes
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
High-dose Cyclophosphamide for Moderate to Severe Refractory Chronic Inflammatory Demyelinating Polyneuropathy
- Status
- WITHDRAWN
- Phase
- PHASE2
Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma
- Status
- COMPLETED
- Phase
- PHASE3
Clofarabine or High-Dose Cytarabine and Pegaspargase in Children with ALL
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma
- Status
- COMPLETED
- Phase
- PHASE2
Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Ex Vivo-Expanded HER2-Specific T Cells and Cyclophosphamide After Vaccine Therapy in Treating Patients With HER2-Positive Stage IV Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1
CAR T Cell Receptor Immunotherapy Targeting VEGFR2 for Patients With Metastatic Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Treated Blood Cells, Cyclophosphamide, Fludarabine Phosphate, and Aldesleukin in Treating Patients With Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Tacrolimus Versus Cyclophosphamide as Treatment for Lupus Nephritis
- Status
- COMPLETED
- Phase
- PHASE1
Trial of Mesna to Prevent Doxorubicin-induced Plasma Protein Oxidation and Tumor Necrosis Factor Alpha (TNF-α) Release
- Status
- COMPLETED
- Phase
- PHASE2
Lapatinib or Trastuzumab Given Prior to Surgery With Chemotherapy in Patients With Early Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study of Rituximab (MabThera) Subcutaneous (SC) Versus Rituximab (MabThera) Intravenous in Participannts With Follicular Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3
Lendexal in Patients With Primary Systemic Amyloidosis (AL) Newly Diagnosed
- Status
- COMPLETED
- Phase
- PHASE2
Vorinostat and Combination Chemotherapy With Rituximab in Treating Patients With HIV-Related Diffuse Large B-Cell Non-Hodgkin Lymphoma or Other Aggressive B-Cell Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Cyclophosphamide Plus Cyclosporine in Treatment-Naive Severe Aplastic Anemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3